Abstract
X-ray diffraction studies reveal the structure of {[(1,7-C 2B 10H 11-1-COO)Bu 2Sn] 2O} 12 to be analogous to most other {[RCOO)Bu 2Sn] 2)O} 2 compounds. The dimer features a central Bu 4Sn 2O 2 unit with the two Bu 2Sn groups being linked via bridging oxygen atoms, each of which also carries an exocyclic Bu2Sn moiety. The two pairs of exo- and endo-cyclic tin atoms are each linked via a symmetrically bridging carboxylate ligand and the two remaining ligands coordinate the exocyclic tin atom only, in the monodentate mode. The in vitro anti-tumour activity of this compound, against a variety of cell lines, is compared with those of clinically used compounds.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.